One receptor, thousands of downstream molecules
A single hormone or growth-factor molecule binding one receptor on a cell's surface can end up switching on thousands of downstream molecules inside the cell within minutes. That enormous gain does not come from the receptor itself doing thousands of jobs — it comes from a signalling cascade: a chain of enzymes, each one activated by the previous step, each one able to activate many copies of the next step before it is switched off. Amplification compounds multiplicatively at every stage of the chain.
Phosphorylation as the switch
The molecular mechanism repeated at each stage is usually phosphorylation: a kinase enzyme transfers a phosphate group from ATP onto a specific serine, threonine or tyrosine residue of its target protein, which changes that target's shape enough to switch it from inactive to active (or vice versa). Crucially, an activated kinase is catalytic — it doesn't get consumed phosphorylating its targets, so one active kinase molecule can phosphorylate, and thereby activate, many copies of the next enzyme in the chain before it is itself deactivated (usually by a phosphatase removing its own activating phosphate). Chain three or four such kinase-activates-kinase steps together and the amplification multiplies at each link.
1 receptor activated
→ activates ~10-100 copies of kinase 1 (first amplification)
→ each activates ~10-100 copies of kinase 2 (second amplification)
→ each activates ~10-100 copies of kinase 3 (third amplification)
= up to 10³–10⁶ downstream molecules activated from one receptor event
The MAPK cascade: a worked example
The best-studied example is the Ras-Raf-MEK-ERK (MAPK) cascade, used across essentially all animal cells to relay growth-factor signals to gene expression. A growth factor binds a receptor tyrosine kinase, triggering activation of the small GTPase Ras; active Ras recruits and activates Raf (a kinase); active Raf phosphorylates and activates MEK; active MEK phosphorylates and activates ERK; active ERK translocates into the nucleus and phosphorylates transcription factors that switch on genes controlling cell division, differentiation or survival, depending on the cell type and the dynamics of the signal. Each of those four links is itself a small amplifying, catalytic step, and the whole chain converts a transient extracellular binding event into a durable change in gene expression.
Why cascades, not a single big switch
Multiple sequential stages buy the cell several things a single amplifying step could not. Signal integration: because several cascades often share intermediate kinases or converge on the same downstream targets, a cell can combine inputs from multiple receptors before committing to a response. Ultrasensitivity and thresholding: passing a signal through several sequential, saturable steps sharpens a graded input into something closer to a switch-like, all-or-nothing output at the far end — a phenomenon called zero-order ultrasensitivity when each kinase/phosphatase pair operates near enzyme saturation. Timing and adaptation: each stage takes a finite time to activate and deactivate, so multi-step cascades naturally build in delays, and feedback loops from downstream steps back onto earlier ones (both negative and positive) can produce transient pulses, sustained on-states, or oscillations, depending on what response the cell needs.
When the amplifier itself becomes the disease
Because a cascade multiplies a small input into a large output, a mutation that locks just one link permanently "on" — a Ras mutation that can no longer switch itself off, for instance — floods every downstream step with a signal the cell never asked for, driving uncontrolled proliferation. Ras mutations of exactly this kind are among the most common oncogenic mutations found across human cancers, which is precisely why the MAPK cascade is one of the most heavily targeted pathways in cancer drug development.
Frequently asked questions
How can binding of a single molecule affect thousands of molecules inside the cell?
Each kinase in the cascade is a catalytic enzyme, not a one-time messenger, so one active kinase molecule can phosphorylate and activate many copies of the next kinase before it is switched off. Chaining several such amplifying steps together compounds the effect multiplicatively, turning one receptor-binding event into activation of thousands of downstream molecules.
What does phosphorylation actually do to a protein?
A kinase enzyme attaches a phosphate group to a specific amino acid on the target protein, which changes the protein's three-dimensional shape enough to switch its activity on or off. The phosphate is later removed by a phosphatase enzyme, which resets the protein back to its original state and makes the switch reversible.
Why is the Ras-Raf-MEK-ERK cascade so important in cancer research?
This MAPK cascade relays growth-factor signals into decisions about cell division, and mutations that lock an early step like Ras permanently active flood every downstream stage with an uncontrolled 'grow' signal. Because such mutations are among the most common found across human cancers, the pathway is one of the most heavily studied targets for cancer drug development.
Try it live
Everything above runs in your browser — open Cell Signalling Cascade and change the parameters while it is running. Nothing is installed, nothing is uploaded, the whole model lives in one tab.
▶ Open Cell Signalling Cascade simulation